112 related articles for article (PubMed ID: 23551109)
1. [131I]IAZA as a molecular radiotherapeutic (MRT) drug: wash-out with cold IAZA accelerates clearance in a murine tumor model.
Mercer JR; McEwan AJ; Wiebe LI
Curr Radiopharm; 2013 Jun; 6(2):87-91. PubMed ID: 23551109
[TBL] [Abstract][Full Text] [Related]
2. [131I]Iodoazomycin arabinoside for low-dose-rate isotope radiotherapy: radiolabeling, stability, long-term whole-body clearance and radiation dosimetry estimates in mice.
Kumar P; McQuarrie SA; Zhou A; McEwan AJ; Wiebe LI
Nucl Med Biol; 2005 Aug; 32(6):647-53. PubMed ID: 16026712
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics of 123I-IAZA in healthy volunteers.
Stypinski D; Wiebe LI; McEwan AJ; Schmidt RP; Tam YK; Mercer JR
Nucl Med Commun; 1999 Jun; 20(6):559-67. PubMed ID: 10451869
[TBL] [Abstract][Full Text] [Related]
4. Dosimetry estimations for 123I-IAZA in healthy volunteers.
Stypinski D; McQuarrie SA; Wiebe LI; Tam YK; Mercer JR; McEwan AJ
J Nucl Med; 2001 Sep; 42(9):1418-23. PubMed ID: 11535735
[TBL] [Abstract][Full Text] [Related]
5. Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results.
Reischl G; Dorow DS; Cullinane C; Katsifis A; Roselt P; Binns D; Hicks RJ
J Pharm Pharm Sci; 2007; 10(2):203-11. PubMed ID: 17706178
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, radiolabeling, and biodistribution of putative metabolites of iodoazomycin arabinoside.
Lee HC; Kumar P; McEwan AJ; Wiebe LI; Mercer JR
Nucl Med Biol; 2000 Jan; 27(1):61-8. PubMed ID: 10755647
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and Scintigraphic Imaging of the Hypoxia-Imaging Agent [
Stypinski D; McQuarrie SA; McEwan AJB; Wiebe LI
Pharmaceutics; 2018 Feb; 10(1):. PubMed ID: 29470434
[TBL] [Abstract][Full Text] [Related]
8. Radioiodinated 1-(5-iodo-5-deoxy-beta-D-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): a novel marker of tissue hypoxia.
Mannan RH; Somayaji VV; Lee J; Mercer JR; Chapman JD; Wiebe LI
J Nucl Med; 1991 Sep; 32(9):1764-70. PubMed ID: 1880579
[TBL] [Abstract][Full Text] [Related]
9. Effects of methoxyflurane anesthesia on the pharmacokinetics of 125I-IAZA in Sprague-Dawley rats.
Stypinski D; Wiebe LI; Tam YK; Mercer JR; McEwan AJ
Nucl Med Biol; 1999 Nov; 26(8):959-65. PubMed ID: 10708311
[TBL] [Abstract][Full Text] [Related]
10. A rapid and simple assay to determine the blood and urine concentrations of 1-(5-[123/125I]iodo-5-deoxyarabinofuranosyl)-2-nitroimidazole, a hypoxic cell marker.
Stypinski D; Wiebe LI; Mercer JR
J Pharm Biomed Anal; 1998 Feb; 16(6):1067-73. PubMed ID: 9547711
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study.
Parliament MB; Chapman JD; Urtasun RC; McEwan AJ; Golberg L; Mercer JR; Mannan RH; Wiebe LI
Br J Cancer; 1992 Jan; 65(1):90-5. PubMed ID: 1310253
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models.
Mahy P; De Bast M; de Groot T; Cheguillaume A; Gillart J; Haustermans K; Labar D; Grégoire V
Radiother Oncol; 2008 Dec; 89(3):353-60. PubMed ID: 18649964
[TBL] [Abstract][Full Text] [Related]
13. Galactose-based Thermosensitive Nanogels for Targeted Drug Delivery of Iodoazomycin Arabinofuranoside (IAZA) for Theranostic Management of Hypoxic Hepatocellular Carcinoma.
Quan S; Wang Y; Zhou A; Kumar P; Narain R
Biomacromolecules; 2015 Jul; 16(7):1978-86. PubMed ID: 25996799
[TBL] [Abstract][Full Text] [Related]
14. Radioiodinated 1-(2-fluoro-4-iodo-2,4-dideoxy-beta-L-xylopyranosyl)-2-nitroimidazole: a novel probe for the noninvasive assessment of tumor hypoxia.
Mannan RH; Mercer JR; Wiebe LI; Somayaji VV; Chapman JD
Radiat Res; 1992 Dec; 132(3):368-74. PubMed ID: 1475360
[TBL] [Abstract][Full Text] [Related]
15. Radioiodinated azomycin pyranoside (IAZP): a novel non-invasive marker for the assessment of tumor hypoxia.
Mannan RH; Mercer JR; Wiebe LI; Kumar P; Somayaji VV; Chapman JD
J Nucl Biol Med (1991); 1992; 36(1):60-7. PubMed ID: 1450228
[TBL] [Abstract][Full Text] [Related]
16. Chemical design of radiolabeled antibody fragments for low renal radioactivity levels.
Arano Y; Fujioka Y; Akizawa H; Ono M; Uehara T; Wakisaka K; Nakayama M; Sakahara H; Konishi J; Saji H
Cancer Res; 1999 Jan; 59(1):128-34. PubMed ID: 9892197
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution of Alpha-Fetoprotein-Containing Noncovalent Complex Aimpila with Antitumor Activity.
Grigor'eva EY; Treshchalina EM; Lipengolts AA; Smirnova AV; Smirnova GB; Borisova YA; Kalishyan MS
Bull Exp Biol Med; 2017 Dec; 164(2):195-198. PubMed ID: 29177873
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 1-beta-D-(5-deoxy-5-iodoarabinofuranosyl)-2-nitroimidazole (beta-IAZA): a novel marker of tissue hypoxia.
Kumar P; Ohkura K; Beiki D; Wiebe LI; Seki K
Chem Pharm Bull (Tokyo); 2003 Apr; 51(4):399-403. PubMed ID: 12672991
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Biological Evaluation of Iodoglucoazomycin (I-GAZ), an Azomycin-Glucose Adduct with Putative Applications in Diagnostic Imaging and Radiotherapy of Hypoxic Tumors.
Kumar P; Elsaidi HR; Zorniak B; Laurens E; Yang J; Bacchu V; Wang M; Wiebe LI
ChemMedChem; 2016 Aug; 11(15):1638-45. PubMed ID: 27377671
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of [131I]iodoerythronitroimidazole as a predictor for the radiosensitizing effect.
Inoue T; Yang DJ; Wallace S; Cherif A; Tansey W; Kim EE; Hunter N; Milross CG; Milas L; Podoloff DA
Anticancer Drugs; 1996 Nov; 7(8):858-65. PubMed ID: 8991190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
